Ajuste direto para aquisição de RISPERIDONA [100 MG/0.490 ML; PÓ SUSP INJ LP; SERINGA] e RISPERIDONA [75 MG/0.383 ML; PÓ SUSP INJ LP; SERINGA]

ID 13560357 · Portal BASE
Price
Base Price
€597,008 .00
Effective Price
€6,069 .00 -99.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Porto, Póvoa de Varzim
Bidder Count
—
Winner
OVERPHARMA - PRODUTOS MÉDICOS E FARMACÊUTICOS LDA
NIF 505792362
Company
Dates
Publication
23 Feb 2026
Celebration
22 Jan 2026
Contracting Entity
Unidade Local de Saúde da Póvoa de Varzim/Vila do Conde, EPE
NIF 508741823
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 50 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
23 Feb 2026
Signing Date
22 Jan 2026
Days Late
32
Rule
A2/A3 late publication: 32 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
597008.0
Total effective price
6069.0
Ratio
0.0102
Direction
reduction
Rule
A9 price reduction: ratio 0.0102 outside [0.5, 1.5]
Detected 2026-03-06